Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris K Hansen

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Hematology. American Society of Hematology. Education Program|December 5, 2025
CAR T-cell therapy and bispecific antibodies in the management of multiple myelomaDanai Dima, Rahul Banerjee, Doris K Hansen
Best Practice & Research. Clinical Haematology|October 9, 2021
Toxicities associated with adoptive cellular therapiesDoris K Hansen, Marian Dam, Rawan G Faramand
Blood Advances|June 3, 2026
Targeting BCMA in Patients with Relapsed/Refractory Multiple Myeloma in 1-3 Prior Lines of TherapyDoris K Hansen, Maria-Victoria Mateos, Luciano J Costa
Hematology. American Society of Hematology. Education Program|December 5, 2025
Demystifying the diagnosis and management of ICUS, CHIP, and CCUSZhuoer Xie, Dae Hyun Lee, Doris K Hansen, et al.
Seminars in Oncology|February 27, 2022
The knowns and unknowns of disparities, biology, and clinical outcomes in Hispanic and Latinx multiple myeloma patients in the U.SLauren C Peres, Doris K Hansen, Francesco Maura, et al.
Annals of Hematology|October 10, 2022
Efficacy and safety of selinexor-based regimens for relapsed/refractory multiple myeloma: a systematic review of literatureAdeel Masood, Qamar Iqbal, Hamid Ehsan, et al.
Clinical Transplantation|July 3, 2023
Impact of weight and creatinine adjustments on the accuracy of Cockcroft-gault equation in hematopoietic cell transplant patientsNatasha A Emanuel, Samantha Price, Doris K Hansen, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2025
Optimizing Selection of Bridging Therapies Prior to CAR-T Therapy Administration for Multiple Myeloma: Clinical Pearls From an Expert RoundtableSikander Ailawadhi, Larry D Anderson, Binod Dhakal, et al.
Acta Haematologica|May 8, 2024
Toxicity of CAR T-Cell Therapy for Multiple MyelomaAimaz Afrough, Pearl Rajan Abraham, Laura Turer, et al.
Journal of Patient Experience|September 28, 2023
Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver PerspectiveDoris K Hansen, Todd Bixby, Karen Fixler, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Hematology. American Society of Hematology. Education Program|December 5, 2025
CAR T-cell therapy and bispecific antibodies in the management of multiple myelomaDanai Dima, Rahul Banerjee, Doris K Hansen
Best Practice & Research. Clinical Haematology|October 9, 2021
Toxicities associated with adoptive cellular therapiesDoris K Hansen, Marian Dam, Rawan G Faramand
Blood Advances|June 3, 2026
Targeting BCMA in Patients with Relapsed/Refractory Multiple Myeloma in 1-3 Prior Lines of TherapyDoris K Hansen, Maria-Victoria Mateos, Luciano J Costa
Hematology. American Society of Hematology. Education Program|December 5, 2025
Demystifying the diagnosis and management of ICUS, CHIP, and CCUSZhuoer Xie, Dae Hyun Lee, Doris K Hansen, et al.
Seminars in Oncology|February 27, 2022
The knowns and unknowns of disparities, biology, and clinical outcomes in Hispanic and Latinx multiple myeloma patients in the U.SLauren C Peres, Doris K Hansen, Francesco Maura, et al.
Annals of Hematology|October 10, 2022
Efficacy and safety of selinexor-based regimens for relapsed/refractory multiple myeloma: a systematic review of literatureAdeel Masood, Qamar Iqbal, Hamid Ehsan, et al.
Clinical Transplantation|July 3, 2023
Impact of weight and creatinine adjustments on the accuracy of Cockcroft-gault equation in hematopoietic cell transplant patientsNatasha A Emanuel, Samantha Price, Doris K Hansen, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2025
Optimizing Selection of Bridging Therapies Prior to CAR-T Therapy Administration for Multiple Myeloma: Clinical Pearls From an Expert RoundtableSikander Ailawadhi, Larry D Anderson, Binod Dhakal, et al.
Acta Haematologica|May 8, 2024
Toxicity of CAR T-Cell Therapy for Multiple MyelomaAimaz Afrough, Pearl Rajan Abraham, Laura Turer, et al.
Journal of Patient Experience|September 28, 2023
Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver PerspectiveDoris K Hansen, Todd Bixby, Karen Fixler, et al.
Pageof 8